Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

DNA Microarrays02:34

DNA Microarrays

21.5K
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
21.5K
MicroRNAs01:22

MicroRNAs

4.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

24.4K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of Enhanced Cyclooxygenase-2 (COX-2) Inhibitors Beyond Curcumin Through Virtual Screening to Target Inflammation-Related Metabolic Complications.

International journal of molecular sciences·2026
Same author

Circulating MicroRNA Profiles in Pregnant South African Women with Different Types of Diabetes Mellitus.

International journal of molecular sciences·2025
Same author

Gestational Diabetes and the Gut Microbiota: Fibre and Polyphenol Supplementation as a Therapeutic Strategy.

Microorganisms·2024
Same author

Evaluating the Therapeutic Potential of Curcumin and Synthetic Derivatives: A Computational Approach to Anti-Obesity Treatments.

International journal of molecular sciences·2024
Same author

Therapeutic Effects of Curcumin Derivatives against Obesity and Associated Metabolic Complications: A Review of In Vitro and In Vivo Studies.

International journal of molecular sciences·2023
Same author

The Maternal Microbiome and Gestational Diabetes Mellitus: Cause and Effect.

Microorganisms·2023

Related Experiment Video

Updated: Mar 2, 2026

Probe-based Real-time PCR Approaches for Quantitative Measurement of microRNAs
10:28

Probe-based Real-time PCR Approaches for Quantitative Measurement of microRNAs

Published on: April 14, 2015

34.0K

MicroRNA Expression Varies according to Glucose Tolerance, Measurement Platform, and Biological Source.

S Dias1,2, S Hemmings3, C Muller1,4,5

  • 1Biomedical Research and Innovation Platform (BRIP), South African Medical Research Council, Tygerberg, South Africa.

Biomed Research International
|May 23, 2017
PubMed
Summary

MicroRNA (miRNA) profiling in South African women revealed inconsistent results between measurement platforms and sample types. However, increased miR-27b in impaired glucose tolerance may serve as a valuable type 2 diabetes biomarker.

More Related Videos

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
10:37

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform

Published on: November 30, 2016

8.7K
Cerebrospinal Fluid MicroRNA Profiling Using Quantitative Real Time PCR
09:26

Cerebrospinal Fluid MicroRNA Profiling Using Quantitative Real Time PCR

Published on: January 22, 2014

16.0K

Related Experiment Videos

Last Updated: Mar 2, 2026

Probe-based Real-time PCR Approaches for Quantitative Measurement of microRNAs
10:28

Probe-based Real-time PCR Approaches for Quantitative Measurement of microRNAs

Published on: April 14, 2015

34.0K
Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
10:37

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform

Published on: November 30, 2016

8.7K
Cerebrospinal Fluid MicroRNA Profiling Using Quantitative Real Time PCR
09:26

Cerebrospinal Fluid MicroRNA Profiling Using Quantitative Real Time PCR

Published on: January 22, 2014

16.0K

Area of Science:

  • Molecular biology
  • Endocrinology
  • Genomics

Background:

  • MicroRNA (miRNA) dysregulation is linked to type 2 diabetes (T2D).
  • Consistency of miRNA expression across platforms and sample types is unclear.
  • Limited research exists on miRNA profiling in diverse populations like South African women.

Purpose of the Study:

  • To profile miRNA expression in whole blood and serum of South African women with varying glucose tolerance.
  • To assess the consistency of miRNA expression using next-generation sequencing (NGS) and quantitative real-time PCR (qRT-PCR).
  • To identify potential miRNA biomarkers for type 2 diabetes risk stratification.

Main Methods:

  • miRNA profiling using NGS on whole blood samples from women with T2D, impaired glucose tolerance (IGT), and normal glucose tolerance (NGT).
  • Validation of selected miRNA candidates using qRT-PCR in both whole blood and serum.
  • Functional enrichment analysis of validated miRNA targets to identify associated biological pathways.

Main Results:

  • Poor correlation observed between miRNA expression data from NGS and qRT-PCR, and between whole blood and serum samples.
  • Only miR-27b showed a consistent, significant increase in women with IGT compared to NGT across both platforms and sample types.
  • Functional analysis linked miR-27b targets to pathways involved in glucose transport and insulin regulation.

Conclusions:

  • Measurement platform and biological source significantly impact miRNA profiling results.
  • Consistently elevated miR-27b in IGT suggests its potential as a biomarker for early T2D risk in this population.
  • Further validation is needed to confirm miR-27b's utility in clinical risk stratification.